Michael J. Koren
Michael J. Koren publishes mostly in Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism, on topics such as Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #115,655 of 7,710,434 ranked researchers
- Rank in United States
- #44,077 of 1,627,098
- Works
- 152
- Citations
- 17k
- Citations per work
- 111.0
What does Michael J. Koren research?
Michael J. Koren's work is mostly in Medicine (49%), Economics, Econometrics and Finance (9%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7549.1%
- Medicine7549.1%
- Everything else4730.9%
- Life Sciences1711.0%
- Social Sciences149.0%
- 1Surgery28% of their works
- 2Cardiology and Cardiovascular Medicine12% of their works
- 3Endocrinology, Diabetes and Metabolism9% of their works
- 4Economics and Econometrics9% of their works
- 5Cancer Research6% of their works
- 6Immunology5% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Cancer, Lipids, and Metabolism
- Atherosclerosis and Cardiovascular Diseases
- Blood Pressure and Hypertension Studies
- Protease and Inhibitor Mechanisms
Which keywords describe Michael J. Koren's research?
The keywords of their largest research topics: Statins, Cardiovascular Disease Prevention, Cholesterol-lowering, Atherosclerosis, Cholesterol, Cardiovascular Disease, Diabetes and Metabolic Syndrome.
- Tissue Inhibitors of Metalloproteinases
- Hypertension
- Lipid Metabolism
- Immune Response
- Generic Drugs
- Quality of Life
- Metabolic Syndrome
- Cardiovascular Disease
- Atherosclerosis
- Cardiovascular Disease Prevention
- Statins
- Cholesterol-lowering
- Cholesterol
- Diabetes
- Cost-effectiveness Analysis
- Drug Development Costs
- Fatty Acid Synthase
- Inflammation
- Blood Pressure
- Matrix Metalloproteinases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Statins1102 topics
- Cardiovascular Disease Prevention961 topic
- Cholesterol-lowering961 topic
- Atherosclerosis352 topics
- Cholesterol352 topics
- Cardiovascular Disease322 topics
- Diabetes211 topic
- Metabolic Syndrome211 topic
- Cost-effectiveness Analysis201 topic
- Quality of Life201 topic
- Drug Development Costs151 topic
- Generic Drugs151 topic
- Fatty Acid Synthase141 topic
- Immune Response141 topic
- Inflammation141 topic
- Lipid Metabolism141 topic
- Blood Pressure111 topic
- Hypertension111 topic
- Matrix Metalloproteinases81 topic
- Tissue Inhibitors of Metalloproteinases81 topic
Where does Michael J. Koren work?
Michael J. Koren's main affiliation in the publication record is Jacksonville Center for Clinical Research, United States.
How many publications and citations does Michael J. Koren have?
OpenAlex counts 152 works and 16,866 citations for Michael J. Koren, an h-index of 48, ranking #115,655 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Michael J. Koren
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael J. Koren. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.